loadpatents
Patent applications and USPTO patent grants for OSTERMANN; Elinborg.The latest application filed is for "anti-cd37 antibodies".
Patent | Date |
---|---|
Anti-cd37 Antibodies App 20210230271 - HEIDER; Karl-Heinz ;   et al. | 2021-07-29 |
Anti Cd37 Antibodies App 20180186876 - HEIDER; Karl-Heinz ;   et al. | 2018-07-05 |
Anti CD37 antibodies Grant 9,932,399 - Heider , et al. April 3, 2 | 2018-04-03 |
Anti Cd37 Antibodies App 20160137729 - HEIDER; Karl-Heinz ;   et al. | 2016-05-19 |
Anti CD37 antibodies Grant 9,078,879 - Heider , et al. July 14, 2 | 2015-07-14 |
Anti Cd37 Antibodies App 20140010808 - HEIDER; Karl-Heinz ;   et al. | 2014-01-09 |
Anti Cd37 Antibodies App 20140004110 - HEIDER; Karl-Heinz ;   et al. | 2014-01-02 |
Anti-IGF antibodies Grant 8,580,254 - Adam , et al. November 12, 2 | 2013-11-12 |
Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them Grant 8,568,727 - Adolf , et al. October 29, 2 | 2013-10-29 |
Anti Cd37 Antibodies App 20110165153 - HEIDER; Karl-Heinz ;   et al. | 2011-07-07 |
Anti-igf Antibodies App 20100196395 - Adam; Paul ;   et al. | 2010-08-05 |
Anti Cd37 Antibodies App 20100189722 - Heider; Karl-Heinz ;   et al. | 2010-07-29 |
Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them App 20090304718 - Adolf; Guenther ;   et al. | 2009-12-10 |
Antibodies specific for CD44v6 Grant 7,417,127 - Adolf , et al. August 26, 2 | 2008-08-26 |
Antibodies specific for CD44v6 Grant 6,972,324 - Adolf , et al. December 6, 2 | 2005-12-06 |
Antibodies specific for CD44v6 App 20050214212 - Adolf, Gunther ;   et al. | 2005-09-29 |
Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof Grant 6,759,211 - Georgiev , et al. July 6, 2 | 2004-07-06 |
Antibodies specific for CD44v6 App 20030190319 - Adolf, Gunther ;   et al. | 2003-10-09 |
Transferrin polycation/DNA complexes for the systemic treatment of tumor diseases with cytotoxic proteins App 20020137670 - Kircheis, Ralf ;   et al. | 2002-09-26 |
Human manganese superoxide dismutase (hMn-SOD) Grant 5,436,162 - Heckl , et al. * July 25, 1 | 1995-07-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.